Patrice Delafontaine MD
Interventional Cardiology, Non-Invasive Cardiology
Executive Dean, Professor of Medicine, Physiology and Pharmacology, Tulane University School of Medicine
Join to View Full Profile
131 S Robertson streetTulane University School of MedicineNew Orleans, LA 70112
Phone+1 504-988-5459
Dr. Delafontaine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1984 - 1987
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1979 - 1980
Rutgers Health/Monmouth Medical CenterInternship, Internal Medicine, 1978 - 1979
University of Geneva Faculty of MedicineClass of 1977
Certifications & Licensure
NY State Medical License 1979 - Present
CA State Medical License 2025 - 2027
FL State Medical License 2021 - 2026
GA State Medical License 1989 - 2026
MA State Medical License 1985 - 2026
MO State Medical License 2015 - 2026
KS State Medical License 2001 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
- Join now to see all
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
- Fellow (FACP) American College of Physicians, 2003
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- EF24, a Curcumin Analog, Reverses Interleukin-18-Induced miR-30a or miR-342-Dependent TRAF3IP2 Expression, RECK Suppression, and the Proinflammatory Phenotype of Human...Yusuke Higashi, Ryan Dashek, Patrice Delafontaine, Randy Scott Rector, Bysani Chandrasekar
Cells. 2024-10-10 - 9 citationsInsulin-like growth factor 1 reduces coronary atherosclerosis in pigs with familial hypercholesterolemia.Sergiy Sukhanov, Yusuke Higashi, Tadashi Yoshida, Svitlana Danchuk, Mitzi Alfortish
JCI Insight. 2023-02-22 - 6 citationsMultiomics Approach Reveals an Important Role of BNIP3 in Myocardial Remodeling and the Pathogenesis of Heart Failure with Reduced Ejection Fraction.Antoine H Chaanine, LeeAnn Higgins, Lothar Lauterboeck, Todd Markowski, Qinglin Yang
Cells. 2022-05-06
Press Mentions
- Tulane Seeks 2,000 Volunteers for Johnson & Johnson Vaccine TrialsNovember 6th, 2020
Tulane University Adds Second Avenue for COVID-19 TestingApril 2nd, 2020
Delafontaine Reinstated at MU Medical SchoolFebruary 18th, 2016
Grant Support
- Insulin-Like Growth Factor-1 and AtherosclerosisTULANE UNIVERSITY OF LOUISIANA2002–2027
- Insulin-Like Growth Factor-1 and AtherosclerosisTULANE UNIVERSITY OF LOUISIANA2002–2027
- Insulin-Like Growth Factor-1 and AtherosclerosisTULANE UNIVERSITY OF LOUISIANA2002–2027
- Angiotensin II, IGF-1 And Skeletal Muscle AtrophyNational Heart, Lung, And Blood Institute2007–2011
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
